纳米启用的基抗菌剂的输送对抗ESKAPE病原体
Ayman Elbehiry1, Eman Marzouk1, Adil Abalkhail1
1Department of Public Health, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia.
Pharmaceutics
|February 27, 2026
概括
纳米技术增强了菌体和基于CRISPR的抗菌素的传递,以对抗多药耐药 (MDR) 逃生病原体. 纳米启用系统提高了稳定性和准性,提供了对抗具有挑战性的感染的有前途的战略.
科学领域:
- * 微生物学和纳米技术
- * 抗微生物耐药性研究
- * 传染病治疗方法 传染病治疗方法
背景情况:
- *由ESKAPE病原体引起的多抗药性 (MDR) 感染 (菌,黄金葡萄球菌,肺炎菌,宝曼菌, Pseudomonas aeruginosa 和 Enterobacter 种类) 构成了重大的临床挑战.
- * 现有的抗微生物策略经常受到细菌耐药机制和药物传递到感染部位的限制的阻碍.
- * 菌体,菌体衍生酶和基于CRISPR的抗微生物药物提供了新的治疗途径,但由于不稳定性,免疫反应和分布不良而面临体内疗效的挑战.
研究的目的:
- * 审查基于纳米技术的输送系统如何克服新型抗菌剂对ESKAPE病原体的局限性.
- *概述ESKAPE病原体所呈现的生物障碍,以及对整个菌体,菌体酶和CRISPR系统的纳米启用输送的潜力.
- * 提出一个框架,将病原体特异性障碍与适当的纳米传递策略相结合,以加强抗菌素暴露.
主要方法:
- *对ESKAPE病原体,抗菌素耐药性机制和纳米技术在药物输送中的应用现有文献进行叙述性审查.
- * 对菌体,菌体衍生酶和基于CRISPR的抗微生物药物的治疗潜力和局限性的分析.
- *对各种纳米技术平台的评估,以提高这些生物制剂的稳定性,局部化和持久性的能力.
主要成果:
- *纳米技术平台可以显著提高细菌菌体,菌体衍生酶和基于CRISPR的抗菌剂的稳定性,组织局部化和持久性.
- * 病原体意识框架将特定的ESKAPE病原体障碍与适合的纳米启用输送策略联系起来,以改善治疗结果.
- * 纳米激活的菌体基疗法证明了一种可行的和适应性的方法来管理MDR ESKAPE感染.
结论:
- *纳米驱动的输送系统对于实现新型抗微生物药物的全部治疗潜力至关重要,例如对MDR病原体的菌体和CRISPR系统.
- *成功管理ESKAPE感染需要一种协同方法,将新抗菌剂的开发与复杂的输送系统设计相结合.
- *新兴方向包括响应性和个性化的纳米输送系统,以进一步优化治疗疗效,解决翻译和监管方面的挑战.
相关概念视频
01:30Lytic Cycle of Bacteriophages
78.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.6K
01:26DNA Bacteriophages
1.2K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.2K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
00:43Lysogenic Cycle of Bacteriophages
68.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.3K
01:28Biological Methods for Microbial Control
1.0K
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
1.0K
01:20Viral Replication: Lytic Cycle
2.0K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
2.0K